SEC Form 4 · accession 0000899243-15-008133
IDEXX LABORATORIES INC /DE · IDXX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jonathan W Ayers
Officer — Chairman, President and CEO · Director
Period of report
Nov 13, 2015
Accepted (ET)
Nov 13, 2015 · 5:05 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000874716
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Nov 13, 2015 | M | 20,174 | $17.185 | A | 961,640 | D | |
| Common Stock | holding | — | — | — | 98,000 | I | By Ayers Family Trust |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-Qualified Stock Option (right-to-buy)F3,F2 | $17.185 | Nov 13, 2015 | M | 20,174 | D | — | Feb 13, 2016 | Common Stock | 20,174 | 0 | D |
Explanation of responses
- F1Includes 99 shares acquired under the IDEXX Laboratories, Inc. Employee Stock Purchase Plan on September 30, 2015.
- F2Grant of option to buy shares of IDEXX Laboratories, Inc. common stock that became exercisable as to 15,999 shares on February 14, 2010 and February 14, 2013, 16,000 shares on February 14, 2011 and February 14, 2012, and the remaining 13,091 shares on February 14, 2014, without giving effect to the 2-for-1 stock split of IDEXX Laboratories, Inc. common stock that occurred on June 15, 2015 (the "Stock Split"). The number of derivative securities reported as beneficially owned with respect to this option and its exercise price were adjusted to reflect the Stock Split.
- F3Not applicable.